Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-30

Clinical Trial Update: GentleCath™ Air Intermittent Catheter Smartwatch Real Life Pilot Study

View source ↗

Summary

Completion of a real-life pilot study evaluating the GentleCath Air intermittent catheter with smartwatch integration for neurogenic bladder management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GentleCath Air Intermittent Catheter (intermittent catheter)

Snippet

Sponsor: ConvaTec Inc. | Conditions: Neurogenic Bladder | Status: COMPLETED